| शेयर बकाया | 26,832,457 shares |
| इनसाइडर शेयर | 1,118,641 shares |
| इनसाइडर ओनरशिप | 4.17 % |
| टोटल इनसाइडर | 61 |
इनसाइडर सेंटीमेंट स्कोर
इनसाइडर सेंटीमेंट स्कोर उन कंपनियों का पता लगाता है जिन्हें कॉर्पोरेट इनसाइडर द्वारा खरीदा जा रहा है।
यह एक परिष्कृत, बहु-कारक मात्रात्मक मॉडल का परिणाम है जो इनसाइडर संचय के उच्चतम स्तर वाली कंपनियों की पहचान करता है। स्कोरिंग मॉडल पिछले 90 दिनों में खरीदने वाले इनसाइडर की शुद्ध संख्या, फ्लोट के प्रतिशत के रूप में खरीदे गए कुल शेयर और इनसाइडर के स्वामित्व वाले कुल शेयरों के संयोजन का उपयोग करता है। संख्या 0 से 100 तक होती है, उच्च संख्याएं अपने प्रतिद्वंदिओ के लिए संचय के उच्च स्तर का संकेत देती हैं, और 50 औसत है।
अपडेट फ्रीक्वेंसी: दैनिक
इनसाइडर्स टॉप पिक्स देखें, जो उच्चतम इनसाइडर संचय वाली कंपनियों की एक सूची प्रदान करता है।
ऑफिसर सेंटीमेंट स्कोर
ऑफिसर सेंटीमेंट स्कोर से पता चलता है कि कंपनियों को कॉर्पोरेट ऑफिसर द्वारा खरीदा जा रहा है।
परिभाषा के अनुसार कॉर्पोरेट ऑफिसर कॉर्पोरेट इनसाइडर्स होते हैं, लेकिन कुछ अन्य इनसाइडर्स (10% शेयरधारक और बोर्ड सदस्य) के विपरीत, ऑफिसर कंपनी के लिए दैनिक आधार पर काम करते हैं, और व्यापार करते समय वे अपने स्वयं के पैसे का उपयोग करते हैं। (10% शेयरधारक और बोर्ड सदस्य अक्सर अन्य लोगों के पैसे का प्रबंधन करने वाले फंड मैनेजर होते हैं।) इस प्रकार, ऑफिसर द्वारा किए गए इनसाइडर व्यापार बहुत अधिक महत्वपूर्ण होते हैं और उनके साथ उचित व्यवहार किया जाना चाहिए।
इनसाइडर सेंटीमेंट स्कोर की तरह, ऑफिसर सेंटीमेंट स्कोर एक परिष्कृत, बहु-कारक मात्रात्मक मॉडल का परिणाम है जो उच्चतम स्तर के ऑफिसर संचय वाली कंपनियों की पहचान करता है।
अपडेट फ्रीक्वेंसी: दैनिक
इनसाइडर्स टॉप पिक्स देखें, जो उच्चतम इनसाइडर सेंटीमेंट वाली कंपनियों की एक सूची प्रदान करता है।
मुख्य इनसाइडर मेट्रिक्स
यह कार्ड दिखाता है कि कंपनी विभिन्न इनसाइडर मेट्रिक्स के साथ कैसे रैंक करती है। प्रतिशतक रैंक से पता चलता है कि यह कंपनी अमेरिकी बाज़ारों में अन्य कंपनियों से कैसे तुलना करती है। ऊंची रैंकिंग बेहतर स्थितियों का संकेत है।
उदाहरण के लिए, यह आम तौर पर स्वीकार किया जाता है कि इनसाइडर खरीदारी एक सकारात्मक संकेतक है, इसलिए अधिक इनसाइडर खरीदारी वाली कंपनियां कम इनसाइडर खरीदारी (या यहां तक कि इनसाइडर बिक्री) वाली कंपनियों की तुलना में उच्च रैंक पर होंगी।
इनसाइडर द्वारा खरीदे गए फ़्लोट का प्रतिशत (रैंक)
0.000 %( )
1248 out of 11237इनसाइडर द्वारा खरीदे गए फ्लोट का प्रतिशत इनसाइडर द्वारा खरीदे गए शेयरों की कुल संख्या है, जिसमें पिछले 90 दिनों में इनसाइडर द्वारा बेचे गए शेयरों की कुल संख्या को घटाकर, कुल फ्लोट से विभाजित किया जाता है और 100 से गुणा किया जाता है।
इनसाइडर ट्रेडिंग चार्ट
Syros Pharmaceuticals, Inc. इनसाइडर व्यापार निम्नलिखित चार्ट में दिखाए गए हैं। इनसाइडर किसी कंपनी के ऑफिसर, निदेशक या महत्वपूर्ण निवेशक होते हैं। सामान्य तौर पर, इनसाइडर के लिए सामग्री, गैर-सार्वजनिक जानकारी के आधार पर अपनी कंपनियों में व्यापार करना आम तौर पर अवैध है। इसका मतलब यह नहीं है कि उनके लिए अपनी कंपनियों में कोई भी व्यापार करना गैरकानूनी है। हालाँकि, उन्हें फॉर्म 4 के माध्यम से SEC को सभी ट्रेडों की रिपोर्ट करनी होगी।
इनसाइडर रोस्टर और प्रॉफिटेबिलिटी मेट्रिक्स
यह तालिका ज्ञात इनसाइडर की सूची दिखाती है, और SEC को बताई गई फाइलिंग से स्वचालित रूप से उत्पन्न होती है। नामों, सबसे हालिया शीर्षक, और निदेशक, ऑफिसर, या 10% मालिक पदनाम के अलावा, हम नवीनतम प्रकट होल्डिंग्स प्रदान करते हैं। इसके अतिरिक्त, जब भी संभव हो हम इनसाइडर के लिए ऐतिहासिक व्यापार प्रदर्शन प्रदान करते हैं। ऐतिहासिक व्यापार प्रदर्शन इनसाइडर द्वारा किए गए वास्तविक खुले बाजार खरीद लेनदेन के प्रदर्शन का एक भारित औसत है। इसकी गणना कैसे की जाती है, इसके बारे में अधिक जानकारी के लिए, यह YouTube वेबिनार देखें।
See our leaderboard of most profitable insider traders.
| इनसाइडर | औसत लाभ (%) | शेयर ओन्ड |
विभाजित समायोजित |
|---|---|---|---|
|
Noubar Afeyan
10% Owner -
|
0 | 0 | |
|
Aisling Capital Iii Lp
10% Owner -
|
908,565 | 90,856 | |
| Srinivas Akkaraju Director - [D] | 9,333 | 9,333 | |
|
ARCH Venture Partners VII, L.P.
10% Owner -
|
4,242,051 | 424,205 | |
|
ARCH Venture Partners VII, LLC
10% Owner -
|
4,242,051 | 424,205 | |
|
Aisling Capital Partners III LLC
10% Owner -
|
908,565 | 90,856 | |
|
Aisling Capital Partners III LP
10% Owner -
|
908,565 | 90,856 | |
| Mark J Alles Director - [D] | 3,666 | 3,666 | |
|
Arch Venture Fund VII LP
10% Owner -
|
4,242,051 | 424,205 | |
| Michael W Bonney | 11,000 | ||
|
Clinton Bybee
10% Owner -
|
4,242,051 | 424,205 | |
| Stephane Bancel Director - [D] | 47,980 | 4,798 | |
|
Keith Crandell
10% Owner -
|
4,242,051 | 424,205 | |
| Conley Chee President & CEO, Director - [D] [O] | 0 | 0 | |
|
Management Co Deerfield
10% Owner -
|
628,566 | 62,857 | |
| Colleen Elizabeth DeSimone Principal Accounting Officer - [O] | 0 | 0 | |
|
Deerfield Mgmt III, L.P.
10% Owner -
|
628,566 | 62,857 | |
|
Deerfield Mgmt L.P.
10% Owner -
|
628,566 | 62,857 | |
|
Deerfield Private Design Fund III, L.P.
10% Owner -
|
628,566 | 62,857 | |
|
Deerfield Special Situations Fund, L.P.
10% Owner -
|
628,566 | 62,857 |
| इनसाइडर | औसत लाभ (%) | शेयर ओन्ड |
विभाजित समायोजित |
|---|---|---|---|
| Deborah Dunsire Director - [D] | 12,000 | 12,000 | |
|
Steve Elms
10% Owner -
|
908,565 | 90,856 | |
| Sue Gail Eckhardt Director - [D] | 16,000 | 16,000 | |
| Marsha Fanucci Director - [D] | 16,000 | 16,000 | |
| Joseph J Jr Ferra Chief Financial Officer - [O] | 87,000 | 8,700 | |
|
Flagship VentureLabs IV, LLC
10% Owner -
|
0 | 0 | |
|
Flagship Ventures Fund IV General Partner LLC
10% Owner -
|
0 | 0 | |
|
Flagship Ventures Fund IV, L.P.
10% Owner -
|
0 | 0 | |
|
Flagship Ventures Fund IV-Rx, L.P.
10% Owner -
|
0 | 0 | |
|
James E Flynn
10% Owner -
|
628,566 | 62,857 | |
|
Nathanael Gray
10% Owner -
|
853,332 | 85,333 | |
|
Jeremy Green
10% Owner -
|
49,793 | 4,979 | |
| Jason Haas Chief Financial Officer - [O] | 0 | 0 | |
|
JEB Syros Trust
10% Owner -
|
703,332 | 70,333 | |
|
Edwin M Jr Kania
10% Owner -
|
0 | 0 | |
| Kuvalanka Kyle D. | 78,000 | ||
|
Robert Nelsen
10% Owner -
|
4,242,051 | 424,205 | |
|
Amir Nashat
Director, 10% Owner -
[D]
|
48,320 | 4,832 | |
| Oh Andrew M. Director - [D] | 16,000 | 16,000 | |
| Eric R Olson Chief Scientific Officer - [O] | 6,661 | 6,661 |
| इनसाइडर | औसत लाभ (%) | शेयर ओन्ड |
विभाजित समायोजित |
|---|---|---|---|
| Sanj K Patel | 11,000 | ||
|
Perspecta Trust LLC
10% Owner -
|
703,332 | 70,333 | |
|
Polaris Entrepreneurs' Fund VII, L.P.
10% Owner -
|
48,320 | 4,832 | |
|
Polaris Management Co. VII, L.L.C.
10% Owner -
|
48,320 | 4,832 | |
|
Polaris Partners VII, L.P.
10% Owner -
|
48,320 | 4,832 | |
|
Dennis J Purcell
10% Owner -
|
908,565 | 90,856 | |
| Gerald E Quirk Chief Legal & Compliance Offic - [O] | 0 | 0 | |
|
Redmile Group, LLC
10% Owner -
|
49,793 | 4,979 | |
| David Roth Chief Medical Officer - [O] | 0 | 0 | |
| Vicki L Sato | 11,000 | ||
|
Andrew N Schiff
10% Owner -
|
908,565 | 90,856 | |
| Philip A Sharp Director - [D] | 40,000 | 4,000 | |
| Alice Tsang Shaw | 22,000 | ||
| Nancy A Simonian Director - [D] | 4,000 | 4,000 | |
| Springhorn Jeremy P. Chief Business Officer - [O] | 35,000 | 3,500 | |
| Kristin Stephens Chief Development Officer - [O] | 0 | 0 | |
| Timothy Tyson Director - [D] | 33,189 | 33,189 | |
| Peter Wirth Director - [D] | 16,000 | 16,000 | |
|
WuXi Healthcare Ventures II, L.P.
10% Owner -
|
423,805 | 42,380 | |
|
WuXi PharmTech Healthcare Fund I L.P.
10% Owner -
|
931,857 | 93,186 | |
| Richard A Young Director - [D] | 10,667 | 10,667 |
Report errors via our new Insider Auditing Tool
इनसाइडर खरीद के ट्रैक रिकॉर्ड - अल्पकालिक लाभ विश्लेषण
इस अनुभाग में, हम SYRS / Syros Pharmaceuticals, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर खरीदारी की लाभप्रदता का विश्लेषण करते हैं। यह विश्लेषण यह समझने में मदद करता है कि क्या इनसाइडर लगातार असामान्य रिटर्न उत्पन्न करता है, और यह अनुसरण करने योग्य है। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और यह परिणाम सैद्धांतिक हैं .
निम्न टेबल्स सबसे हालिया खुले बाज़ार की खरीदारी को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।
समायोजित कीमत विभाजित-समायोजित कीमत है। समायोजित शेयर विभाजित-समायोजित शेयर हैं।
इनसाइडर बिक्री के ट्रैक रिकॉर्ड - अल्पकालिक हानि विश्लेषण
इस अनुभाग में, हम SYRS / Syros Pharmaceuticals, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर बिक्री के अल्पकालिक नुकसान से बचने का विश्लेषण करते हैं। हानि से बचने का एक सुसंगत पैटर्न यह सुझाव दे सकता है कि भविष्य में बिक्री लेनदेन कीमत में गिरावट की भविष्यवाणी कर सकते हैं। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और यह परिणाम सैद्धांतिक हैं .
निम्न टेबल्स सबसे हालिया खुले बाज़ार की बिक्री को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।
समायोजित कीमत विभाजित-समायोजित कीमत है। समायोजित शेयर विभाजित-समायोजित शेयर हैं।
ट्रांजेक्शन इतिहास
संपूर्ण लेन-देन इतिहास देखने के लिए लिंक आइकन पर क्लिक करें। 10b5-1 स्वचालित ट्रेडिंग योजना के भाग के रूप में रिपोर्ट किए गए लेन-देन में 10b-5 चिह्नित कॉलम में एक X अंकित होगा।
| फ़ाइल तिथि |
व्यापार तिथि |
फॉर्म | इनसाइडर | टिकर | प्रतिभूति वर्ग | कोड | प्रत्यक्ष | एक्सरसाइज कीमत |
यूनिट कीमत |
यूनिटस परिवर्तित |
वैल्यू परिवर्तित (1K) |
शेष ऑप्शन |
शेष शेयर |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-04 | 2024-12-02 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 0.2702 | -37,070 | -10 | 4,000 | ||||
| 2024-11-27 | 2024-11-25 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 0.2653 | -134,713 | -36 | 41,070 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Haas Jason | SYRS | Common Stock | D | 0.2103 | -137,803 | -29 | 0 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Chee Conley | SYRS | Common Stock | D | 0.1998 | -134,797 | -27 | 0 | ||||
| 2024-11-20 | 2024-11-19 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 0.2212 | -46,657 | -10 | 0 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Stephens Kristin | SYRS | Common Stock | D | 0.2200 | -36,133 | -8 | 0 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Roth David | SYRS | Common Stock | D | 0.1969 | -12,099 | -2 | 0 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 40,125 | 175,783 | ||||||
| 2024-11-04 | 2024-10-31 | 4 | Chee Conley | SYRS | Common Stock | D | 2.0900 | -8,707 | -18 | 130,797 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Chee Conley | SYRS | Common Stock | D | 17,000 | 139,504 | ||||||
| 2024-11-04 | 2024-10-31 | 4 | Roth David | SYRS | Common Stock | D | 2.0900 | -6,776 | -14 | 12,099 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Roth David | SYRS | Common Stock | D | 18,875 | 18,875 | ||||||
| 2024-11-04 | 2024-10-31 | 4 | Haas Jason | SYRS | Common Stock | D | 2.0900 | -5,624 | -12 | 137,803 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Haas Jason | SYRS | Common Stock | D | 18,875 | 143,427 | ||||||
| 2024-11-04 | 2024-10-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2.0900 | -6,104 | -13 | 36,133 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 17,000 | 42,237 | ||||||
| 2024-10-02 | 2024-09-30 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 2.1000 | -3,100 | -7 | 46,657 | ||||
| 2024-10-02 | 2024-09-30 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 10,000 | 49,757 | ||||||
| 2024-09-18 | 2024-09-16 | 4 | Young Richard A | SYRS | Common Stock | D | 2,667 | 10,667 | ||||||
| 2024-09-18 | 2024-09-16 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | D | 2,667 | 9,333 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Chee Conley | SYRS | Common Stock | D | 1.7084 | 50,000 | 85 | 122,504 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Chee Conley | SYRS | Common Stock | D | 1.5052 | 50,000 | 75 | 72,504 | ||||
| 2024-09-12 | 2024-09-12 | 4 | Haas Jason | SYRS | Common Stock | D | 1.6762 | 45,344 | 76 | 124,552 | ||||
| 2024-09-12 | 2024-09-11 | 4 | Haas Jason | SYRS | Common Stock | D | 1.5781 | 19,293 | 30 | 79,208 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Haas Jason | SYRS | Common Stock | D | 1.5493 | 35,363 | 55 | 59,915 | ||||
| 2024-07-02 | 2024-06-28 | 4 | Young Richard A | SYRS | Common Stock | D | 5.1200 | -34,837 | -178 | 8,000 | ||||
| 2024-06-07 | 2024-06-05 | 4 | OH ANDREW M. | SYRS | Common Stock | D | 4,000 | 16,000 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 4,000 | 135,658 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | WIRTH PETER | SYRS | Common Stock | D | 4,000 | 16,000 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Fanucci Marsha | SYRS | Common Stock | D | 4,000 | 16,000 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Eckhardt Sue Gail | SYRS | Common Stock | D | 4,000 | 16,000 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 4,000 | 33,189 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Young Richard A | SYRS | Common Stock | D | 4,000 | 42,837 | ||||||
| 2024-06-04 | 2024-06-01 | 4 | Dunsire Deborah | SYRS | Common Stock | D | 4,000 | 12,000 | ||||||
| 2024-06-04 | 2024-06-01 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | D | 4,000 | 6,666 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Roth David | SYRS | Common Stock | D | 4.9500 | -10,451 | -52 | 0 | ||||
| 2024-04-02 | 2024-04-01 | 4 | Stephens Kristin | SYRS | Common Stock | D | 5.1200 | -4,218 | -22 | 25,237 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 11,666 | 29,455 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2,000 | 17,789 | ||||||
| 2024-04-02 | 2024-04-01 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 5.1200 | -14,052 | -72 | 131,658 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 39,566 | 145,710 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 6,000 | 106,144 | ||||||
| 2024-04-02 | 2024-04-02 | 4 | Roth David | SYRS | Common Stock | D | 4.9803 | -150 | -1 | 10,451 | ||||
| 2024-04-02 | 2024-04-01 | 4 | Roth David | SYRS | Common Stock | D | 5.1200 | -4,732 | -24 | 10,601 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Roth David | SYRS | Common Stock | D | 13,333 | 15,333 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Roth David | SYRS | Common Stock | D | 2,000 | 2,000 | ||||||
| 2024-04-02 | 2024-03-28 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 5.5900 | -7,046 | -39 | 39,757 | ||||
| 2024-04-02 | 2024-03-27 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 22,500 | 46,803 | ||||||
| 2024-04-02 | 2024-04-01 | 4 | Haas Jason | SYRS | Common Stock | D | 5.1200 | -4,732 | -24 | 24,552 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Haas Jason | SYRS | Common Stock | D | 13,333 | 29,284 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Haas Jason | SYRS | Common Stock | D | 2,000 | 15,951 | ||||||
| 2024-04-02 | 2024-04-01 | 4 | Chee Conley | SYRS | Common Stock | D | 5.1200 | -3,500 | -18 | 22,504 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Chee Conley | SYRS | Common Stock | D | 11,666 | 26,004 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Chee Conley | SYRS | Common Stock | D | 2,000 | 14,338 | ||||||
| 2023-12-26 | 2023-12-21 | 4 | AKKARAJU SRINIVAS By Samsara BioCapital, L.P. | SYRS | Common Stock | I | 4.4200 | 904,977 | 4,000 | 1,786,427 | ||||
| 2023-12-14 | 2023-12-12 | 4 | Roth David | SYRS | Common Stock | D | 4.9500 | -6,287 | -31 | 0 | ||||
| 2023-12-08 | 2023-12-06 | 4 | Roth David | SYRS | Common Stock | D | 3.9500 | -6,287 | -25 | 6,287 | ||||
| 2023-11-02 | 2023-11-01 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 2.2200 | -13,401 | -30 | 100,144 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 40,125 | 113,545 | ||||||
| 2023-11-02 | 2023-11-01 | 4 | Haas Jason | SYRS | Common Stock | D | 2.2200 | -6,301 | -14 | 13,951 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Haas Jason | SYRS | Common Stock | D | 18,875 | 20,252 | ||||||
| 2023-11-02 | 2023-11-01 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2.2200 | -5,676 | -13 | 15,789 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 17,000 | 21,465 | ||||||
| 2023-11-02 | 2023-11-01 | 4 | Roth David | SYRS | Common Stock | D | 2.2200 | -6,301 | -14 | 12,574 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Roth David | SYRS | Common Stock | D | 18,875 | 18,875 | ||||||
| 2023-11-02 | 2023-11-01 | 4 | Chee Conley | SYRS | Common Stock | D | 2.2200 | -6,004 | -13 | 12,338 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Chee Conley | SYRS | Common Stock | D | 17,000 | 18,342 | ||||||
| 2023-10-20 | 2023-10-19 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 2.1000 | -6,897 | -14 | 24,303 | ||||
| 2023-10-20 | 2023-10-11 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 22,500 | 31,200 | ||||||
| 2023-09-19 | 2023-09-16 | 4 | Young Richard A | SYRS | Common Stock | D | 2,666 | 38,837 | ||||||
| 2023-09-19 | 2023-09-16 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | D | 2,666 | 2,666 | ||||||
| 2023-09-19 | 2023-09-16 | 4 | Alles Mark J | SYRS | Common Stock | D | 2,666 | 3,666 | ||||||
| 2023-08-02 | 2023-07-31 | 4 | Roth David | SYRS | Common Stock | D | 3.9500 | -7,348 | -29 | 0 | ||||
| 2023-07-18 | 2023-07-17 | 4 | Olson Eric R | SYRS | Common Stock | D | 3.5000 | -689 | -2 | 6,661 | ||||
| 2023-06-02 | 2023-06-01 | 4 | WIRTH PETER | SYRS | Common Stock | D | 4,000 | 12,000 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Young Richard A | SYRS | Common Stock | D | 4,000 | 36,171 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | OH ANDREW M. | SYRS | Common Stock | D | 4,000 | 12,000 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 4,000 | 29,189 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Eckhardt Sue Gail | SYRS | Common Stock | D | 4,000 | 12,000 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Fanucci Marsha | SYRS | Common Stock | D | 4,000 | 12,000 | ||||||
| 2023-04-20 | 2022-09-16 | 4/A | TYSON TIMOTHY | SYRS | Common Stock | D | 257 | 8,257 | ||||||
| 2023-04-20 | 2022-09-16 | 4/A | TYSON TIMOTHY | SYRS | Common Stock | D | 8,000 | 8,000 | ||||||
| 2023-04-20 | 2022-09-16 | 4/A | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 691,489 | 881,450 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Chee Conley | SYRS | Common Stock | D | 2.5800 | -658 | -2 | 1,342 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Chee Conley | SYRS | Common Stock | D | 2,000 | 2,000 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Olson Eric R | SYRS | Common Stock | D | 2.5800 | -623 | -2 | 7,350 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Olson Eric R | SYRS | Common Stock | D | 2,000 | 7,973 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2.5800 | -623 | -2 | 4,465 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2,000 | 5,088 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 2.5800 | -1,852 | -5 | 73,420 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 6,000 | 75,272 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Haas Jason | SYRS | Common Stock | D | 2.5800 | -623 | -2 | 1,377 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Haas Jason | SYRS | Common Stock | D | 2,000 | 2,000 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Roth David | SYRS | Common Stock | D | 2.5800 | -623 | -2 | 7,348 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Roth David | SYRS | Common Stock | D | 2,000 | 7,971 | ||||||
| 2022-10-13 | 3 | Quirk Gerald E | SYRS | Common Stock | D | 8,700 | ||||||||
| 2022-10-03 | 2022-09-30 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 6.3704 | 14,000 | 89 | 24,932 | ||||
| 2022-10-03 | 2022-09-29 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 5.7196 | 2,932 | 17 | 10,932 | ||||
| 2022-09-19 | 2022-09-16 | 4 | WIRTH PETER | SYRS | Common Stock | D | 8,000 | 8,000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | Fanucci Marsha | SYRS | Common Stock | D | 8,000 | 8,000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | OH ANDREW M. | SYRS | Common Stock | D | 8,000 | 8,000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 8,000 | 8,000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | Eckhardt Sue Gail | SYRS | Common Stock | D | 8,000 | 8,000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | Dunsire Deborah | SYRS | Common Stock | D | 8,000 | 8,000 | ||||||
| 2022-04-04 | 2022-04-01 | 4 | Roth David | SYRS | Common Stock | D | 1.1200 | -27,281 | -31 | 59,719 | ||||
| 2022-04-04 | 2022-04-01 | 4 | Stephens Kristin | SYRS | Common Stock | D | 1.1200 | -14,115 | -16 | 30,885 | ||||
| 2022-04-04 | 2022-04-01 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 1.1200 | -58,883 | -66 | 692,723 | ||||
| 2022-04-04 | 2022-04-01 | 4 | Olson Eric R | SYRS | Common Stock | D | 1.1200 | -27,266 | -31 | 59,734 | ||||
| 2022-02-17 | 2022-02-15 | 4 | Simonian Nancy A | SYRS | Restricted Stock Units | D | 400,000 | 400,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Simonian Nancy A | SYRS | Restricted Stock Units | D | 240,000 | 240,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 1.59 | 375,000 | 375,000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Roth David | SYRS | Restricted Stock Units | D | 200,000 | 200,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Roth David | SYRS | Restricted Stock Units | D | 80,000 | 80,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 1.59 | 125,000 | 125,000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Olson Eric R | SYRS | Restricted Stock Units | D | 200,000 | 200,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Olson Eric R | SYRS | Restricted Stock Units | D | 80,000 | 80,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1.59 | 100,000 | 100,000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Stephens Kristin | SYRS | Restricted Stock Units | D | 200,000 | 200,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Stephens Kristin | SYRS | Restricted Stock Units | D | 80,000 | 80,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Stephens Kristin | SYRS | Stock Option (right to buy) | D | 1.59 | 100,000 | 100,000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Haas Jason | SYRS | Restricted Stock Units | D | 80,000 | 80,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Haas Jason | SYRS | Stock Option (right to buy) | D | 1.59 | 125,000 | 125,000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Chee Conley | SYRS | Restricted Stock Units | D | 80,000 | 80,000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Chee Conley | SYRS | Stock Option (right to buy) | D | 1.59 | 100,000 | 100,000 | |||||
| 2022-01-06 | 2022-01-05 | 4 | Olson Eric R | SYRS | Common Stock | D | 3.4669 | -2,208 | -8 | 0 | ||||
| 2021-10-13 | 2021-10-12 | 4 | Haas Jason | SYRS | Stock Option (right to buy) | D | 4.54 | 750,000 | 750,000 | |||||
| 2021-09-28 | 2021-09-27 | 4 | Chee Conley | SYRS | Stock Option (right to buy) | D | 4.81 | 360,000 | 360,000 | |||||
| 2021-09-10 | 2021-09-09 | 4 | Dunsire Deborah | SYRS | Stock Option (right to buy) | D | 5.28 | 35,000 | 35,000 | |||||
| 2021-07-01 | 2021-07-01 | 4 | Olson Eric R | SYRS | Common Stock | D | 5.5500 | -1,164 | -6 | 0 | ||||
| 2021-06-10 | 2021-06-08 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 6.30 | 17,500 | 17,500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 6.30 | 17,500 | 17,500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | WIRTH PETER | SYRS | Stock Option (right to buy) | D | 6.30 | 17,500 | 17,500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 6.30 | 17,500 | 17,500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 6.30 | 17,500 | 17,500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 6.30 | 17,500 | 17,500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Eckhardt Sue Gail | SYRS | Stock Option (right to buy) | D | 6.30 | 17,500 | 17,500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Alles Mark J | SYRS | Stock Option (right to buy) | D | 6.30 | 17,500 | 17,500 | |||||
| 2021-06-10 | 3 | Stephens Kristin | SYRS | Common Stock | D | 45,000 | ||||||||
| 2021-03-17 | 2021-03-15 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1.01 | -3,628 | 90,697 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Olson Eric R | SYRS | Common Stock | D | 9.4740 | -3,628 | -34 | 0 | ||||
| 2021-03-17 | 2021-03-15 | 4 | Olson Eric R | SYRS | Common Stock | D | 1.0100 | 3,628 | 4 | 3,628 | ||||
| 2021-02-19 | 2021-02-17 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 11.41 | 94,000 | 94,000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 11.41 | 94,000 | 94,000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 11.41 | 94,000 | 94,000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 11.41 | 119,000 | 119,000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 11.41 | 119,000 | 119,000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 11.41 | 304,000 | 304,000 | |||||
| 2021-02-18 | 2021-02-16 | 4 | Young Richard A | SYRS | Common Stock | D | 12.0500 | -3,750 | -45 | 321,711 | ||||
| 2021-02-10 | 2020-11-17 | 4/A | Young Richard A | SYRS | Common Stock | D | 8.7500 | -5,357 | -47 | 329,211 | ||||
| 2021-02-10 | 2020-11-16 | 4/A | Young Richard A | SYRS | Common Stock | D | 8.9800 | -633 | -6 | 334,568 | ||||
| 2021-02-10 | 2021-02-08 | 4 | Young Richard A | SYRS | Common Stock | D | 13.0400 | -3,750 | -49 | 325,461 | ||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 10.09 | -4,988 | 280,012 | |||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 8.51 | -14,168 | 79,165 | |||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3.04 | -10,761 | 21,524 | |||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 10.0900 | 4,988 | 50 | 563,606 | ||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 8.5100 | 14,168 | 121 | 558,618 | ||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 3.0400 | 10,761 | 33 | 544,450 | ||||
| 2020-12-11 | 2020-12-08 | 4 | AKKARAJU SRINIVAS | SYRS | Warrants (right to buy) | I | 11.00 | 156,250 | 156,250 | |||||
| 2020-12-11 | 2020-12-08 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 625,000 | 1,899,616 | ||||||
| 2020-11-18 | 2020-11-17 | 4 | Young Richard A | SYRS | Common Stock | D | 8.7500 | -5,357 | -47 | 339,211 | ||||
| 2020-11-18 | 2020-11-16 | 4 | Young Richard A | SYRS | Common Stock | D | 8.9800 | -633 | -6 | 344,568 | ||||
| 2020-10-19 | 2020-10-19 | 4 | Young Richard A | SYRS | Common Stock | D | 8.7500 | -5,673 | -50 | 335,201 | ||||
| 2020-10-16 | 2020-10-15 | 4 | Young Richard A | SYRS | Common Stock | D | 8.7500 | -317 | -3 | 340,874 | ||||
| 2020-09-16 | 2020-09-15 | 4 | Young Richard A | SYRS | Common Stock | D | 10.3900 | -5,990 | -62 | 341,191 | ||||
| 2020-09-09 | 2020-09-08 | 4 | Eckhardt Sue Gail | SYRS | Stock Option (right to buy) | D | 8.94 | 35,000 | 35,000 | |||||
| 2020-08-19 | 2020-08-17 | 4 | Young Richard A | SYRS | Common Stock | D | 12.5900 | -5,990 | -75 | 347,181 | ||||
| 2020-08-19 | 2020-08-18 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1.01 | -10,787 | 94,325 | |||||
| 2020-08-19 | 2020-08-18 | 4 | Olson Eric R | SYRS | Common Stock | D | 13.0000 | -10,787 | -140 | 0 | ||||
| 2020-08-19 | 2020-08-18 | 4 | Olson Eric R | SYRS | Common Stock | D | 1.0100 | 10,787 | 11 | 10,787 | ||||
| 2020-08-19 | 2020-08-17 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1.01 | -4,963 | 105,112 | |||||
| 2020-08-19 | 2020-08-17 | 4 | Olson Eric R | SYRS | Common Stock | D | 13.0000 | -4,963 | -65 | 0 | ||||
| 2020-08-19 | 2020-08-17 | 4 | Olson Eric R | SYRS | Common Stock | D | 1.0100 | 4,963 | 5 | 4,963 | ||||
| 2020-08-19 | 2020-08-18 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 13.0955 | -158,583 | -2,077 | 1,274,616 | ||||
| 2020-08-19 | 2020-08-17 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 13.0000 | -744 | -10 | 1,433,199 | ||||
| 2020-07-17 | 2020-07-15 | 4 | Young Richard A | SYRS | Common Stock | D | 11.8500 | -5,990 | -71 | 353,171 | ||||
| 2020-07-07 | 2020-07-07 | 4 | Olson Eric R | SYRS | Common Stock | D | 11.7162 | -1,753 | -21 | 0 | ||||
| 2020-07-06 | 2020-07-01 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 11.0149 | -4,627 | -51 | 1,433,943 | ||||
| 2020-06-25 | 2020-06-25 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 11.1484 | -54,972 | -613 | 1,438,570 | ||||
| 2020-06-25 | 2020-06-24 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 11.0669 | -48,775 | -540 | 1,493,542 | ||||
| 2020-06-25 | 2020-06-23 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 11.1069 | -50,953 | -566 | 1,542,317 | ||||
| 2020-06-16 | 2020-06-15 | 4 | Young Richard A | SYRS | Common Stock | D | 8.7500 | -5,990 | -52 | 359,161 | ||||
| 2020-06-11 | 2020-06-11 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 9.17 | 17,500 | 17,500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | WIRTH PETER | SYRS | Stock Option (right to buy) | D | 9.17 | 17,500 | 17,500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 9.17 | 17,500 | 17,500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 9.17 | 17,500 | 17,500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | Alles Mark J | SYRS | Stock Option (right to buy) | D | 9.17 | 17,500 | 17,500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 9.17 | 17,500 | 17,500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 9.17 | 17,500 | 17,500 | |||||
| 2020-05-15 | 2020-05-15 | 4 | Young Richard A | SYRS | Common Stock | D | 9.2224 | -5,990 | -55 | 365,151 | ||||
| 2020-05-13 | 2020-05-13 | 4 | Alles Mark J | SYRS | Common Stock | D | 8.8590 | 10,000 | 89 | 10,000 | ||||
| 2020-04-17 | 2020-04-15 | 4 | Young Richard A | SYRS | Common Stock | D | 8.7500 | -23,960 | -210 | 371,141 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Olson Eric R | SYRS | Common Stock | D | 7.3818 | -1,446 | -11 | 0 | ||||
| 2020-02-14 | 2020-02-13 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 7.54 | 294,000 | 294,000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 7.54 | 94,000 | 94,000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 7.54 | 94,000 | 94,000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 7.54 | 94,000 | 94,000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 7.54 | 94,000 | 94,000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 7.54 | 94,000 | 94,000 | |||||
| 2019-12-23 | 2019-12-23 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3.04 | -8,210 | 1,018,123 | |||||
| 2019-12-23 | 2019-12-23 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3.04 | -10,762 | 1,026,333 | |||||
| 2019-12-23 | 2019-12-23 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3.04 | -33,429 | 1,037,095 | |||||
| 2019-12-23 | 2019-12-23 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 3.0400 | 52,401 | 159 | 533,689 | ||||
| 2019-12-20 | 2019-12-19 | 4 | Alles Mark J | SYRS | Stock Option (right to buy) | D | 6.22 | 35,000 | 35,000 | |||||
| 2019-11-12 | 2019-11-12 | 4 | Springhorn Jeremy P. | SYRS | Common Stock | D | 4.9667 | 10,121 | 50 | 35,000 | ||||
| 2019-11-12 | 2019-11-11 | 4 | Springhorn Jeremy P. | SYRS | Common Stock | D | 4.9932 | 9,879 | 49 | 24,879 | ||||
| 2019-08-19 | 2019-08-16 | 4 | Young Richard A | SYRS | Common Stock | D | 10.0000 | -22,700 | -227 | 395,101 | ||||
| 2019-08-19 | 2019-08-15 | 4 | Young Richard A | SYRS | Common Stock | D | 10.0000 | -2,300 | -23 | 417,801 | ||||
| 2019-07-17 | 2019-07-17 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 7.6964 | -34,521 | -266 | 4,242,051 | ||||
| 2019-07-17 | 2019-07-16 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 7.8078 | -25,779 | -201 | 4,276,572 | ||||
| 2019-07-17 | 2019-07-15 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 8.2651 | -2,700 | -22 | 4,302,051 | ||||
| 2019-06-12 | 2019-06-11 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 5.60 | 11,000 | 11,000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Shaw Alice Tsang | SYRS | Stock Option (right to buy) | D | 5.60 | 22,000 | 22,000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | WIRTH PETER | SYRS | Stock Option (right to buy) | D | 5.60 | 11,000 | 11,000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 5.60 | 11,000 | 11,000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 5.60 | 11,000 | 11,000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | BONNEY MICHAEL W | SYRS | Stock Option (right to buy) | D | 5.60 | 11,000 | 11,000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Fanucci Marsha | SYRS | Common Stock (right to buy) | D | 5.60 | 11,000 | 11,000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 5.60 | 11,000 | 11,000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | SATO VICKI L | SYRS | Common Stock (right to buy) | D | 5.60 | 11,000 | 11,000 | |||||
| 2019-04-11 | 2019-04-09 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock Warrants (rights to buy) | I | 8.62 | 133,333 | 133,333 | |||||
| 2019-04-11 | 2019-04-09 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 7.5000 | 533,332 | 4,000 | 1,593,270 | ||||
| 2019-03-14 | 2019-03-14 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 8.1498 | -43,000 | -350 | 4,305,051 | ||||
| 2019-03-14 | 2019-03-13 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 8.1993 | -2,820 | -23 | 4,348,051 | ||||
| 2019-03-14 | 2019-03-13 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 7.8862 | -81,591 | -643 | 4,350,871 | ||||
| 2019-03-14 | 2019-03-12 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 7.3674 | -40,092 | -295 | 4,432,462 | ||||
| 2019-03-11 | 2019-03-11 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 6.4924 | -44,878 | -291 | 4,472,554 | ||||
| 2019-03-11 | 2019-03-08 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 6.9266 | -84,496 | -585 | 4,517,432 | ||||
| 2019-03-11 | 2019-03-07 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 6.8736 | -35,209 | -242 | 4,601,928 | ||||
| 2019-02-14 | 2019-02-12 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 6.71 | 75,000 | 75,000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Ferra Joseph J Jr | SYRS | Common Stock | D | 87,000 | 87,000 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 6.71 | 75,000 | 75,000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Olson Eric R | SYRS | Common Stock | D | 87,000 | 87,000 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 6.71 | 75,000 | 75,000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 87,000 | 87,000 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 6.71 | 75,000 | 75,000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Roth David | SYRS | Common Stock | D | 87,000 | 87,000 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 6.71 | 285,000 | 285,000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 188,000 | 669,288 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 6.71 | 75,000 | 75,000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Springhorn Jeremy P. | SYRS | Common Stock | D | 87,000 | 102,000 | ||||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3.04 | 12,084 | 785,523 | |||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 1.01 | 75,050 | 797,607 | |||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 1.01 | 23,454 | 872,657 | |||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 3.0400 | 12,084 | 37 | 481,288 | ||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 1.0100 | 98,504 | 99 | 469,204 | ||||
| 2018-06-15 | 2018-06-14 | 4 | BONNEY MICHAEL W | SYRS | Stock Option (right to buy) | D | 12.95 | 13,000 | 13,000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 12.95 | 11,000 | 11,000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 12.95 | 11,000 | 11,000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | SATO VICKI L | SYRS | Stock Option (right to buy) | D | 12.95 | 11,000 | 11,000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 12.95 | 11,000 | 11,000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | WIRTH PETER | SYRS | Stock Option (right to buy) | D | 12.95 | 11,000 | 11,000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 12.95 | 11,000 | 11,000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 12.95 | 11,000 | 11,000 | |||||
| 2018-03-12 | 2018-03-12 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 12.32 | 50,000 | 50,000 | |||||
| 2018-03-12 | 2018-03-12 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 12.32 | 150,000 | 150,000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 10.09 | 75,000 | 75,000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 13.30 | 11,666 | 11,666 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 10.09 | 75,000 | 75,000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 10.09 | 285,000 | 285,000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 10.09 | 75,000 | 75,000 | |||||
| 2018-02-13 | 2017-09-08 | 5 | AFEYAN NOUBAR | SYRS | Common Stock | D | -24,527 | 0 | ||||||
| 2018-02-02 | 2018-01-31 | 4 | AKKARAJU SRINIVAS see footnote 1 | SYRS | Common Stock | I | 9.5500 | 209,424 | 2,000 | 1,059,938 | ||||
| 2017-12-22 | 3/A | AKKARAJU SRINIVAS By Samsara BioCapital, L.P. | SYRS | Common Stock | I | 740,740 | ||||||||
| 2017-12-15 | 2017-12-15 | 4 | Springhorn Jeremy P. | SYRS | Common Stock | D | 9.0840 | 15,000 | 136 | 15,000 | ||||
| 2017-12-14 | 2017-12-14 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 8.9900 | 26,600 | 239 | 830,494 | ||||
| 2017-12-14 | 2017-12-13 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 8.9700 | 68,400 | 614 | 803,894 | ||||
| 2017-12-14 | 2017-12-12 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 9.4000 | 14,774 | 139 | 735,494 | ||||
| 2017-11-14 | 2017-11-13 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 11.65 | 50,000 | 50,000 | |||||
| 2017-11-14 | 2017-11-13 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 11.65 | 150,000 | 150,000 | |||||
| 2017-10-23 | 2017-10-23 | 4 | DeSimone Colleen Elizabeth | SYRS | Stock Option (right to buy) | D | 3.04 | -550 | 13,016 | |||||
| 2017-10-23 | 2017-10-23 | 4 | DeSimone Colleen Elizabeth | SYRS | Common Stock | D | 16.0605 | -550 | -9 | 0 | ||||
| 2017-10-23 | 2017-10-23 | 4 | DeSimone Colleen Elizabeth | SYRS | Common Stock | D | 3.0400 | 550 | 2 | 550 | ||||
| 2017-09-22 | 2017-06-08 | 4/A | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 14.62 | 22,000 | 22,000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 14.62 | 11,000 | 11,000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | Nashat Amir | SYRS | Stock Option (right to buy) | D | 14.62 | 11,000 | 11,000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | Patel Sanj K | SYRS | Stock Option (right to buy) | D | 14.62 | 11,000 | 11,000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | SATO VICKI L | SYRS | Stock Option (right to buy) | D | 14.62 | 11,000 | 11,000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 14.62 | 11,000 | 11,000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | Young Richard A | SYRS | Stock Option (right to buy) | D | 14.62 | 11,000 | 11,000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | NELSEN ROBERT | SYRS | Stock Option (right to buy) | D | 14.62 | 11,000 | 11,000 | |||||
| 2017-08-21 | 2017-08-17 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | -54,293 | 0 | ||||||
| 2017-08-21 | 2017-08-17 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | -306,222 | 612,442 | ||||||
| 2017-08-21 | 2017-08-17 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | D | -1,295,997 | 2,378,663 | ||||||
| 2017-08-16 | 2017-08-14 | 4 | Young Richard A | SYRS | Common Stock | D | 22.0000 | -3,282 | -72 | 420,101 | ||||
| 2017-08-08 | 2017-08-07 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1.01 | 2,500 | 110,075 | |||||
| 2017-08-08 | 2017-08-07 | 4 | Olson Eric R | SYRS | Common Stock | D | 23.5876 | -2,500 | -59 | 0 | ||||
| 2017-08-08 | 2017-08-07 | 4 | Olson Eric R | SYRS | Common Stock | D | 1.0100 | 2,500 | 3 | 2,500 | ||||
| 2017-07-27 | 2017-07-25 | 4 | Young Richard A | SYRS | Common Stock | D | 22.0889 | -3,282 | -72 | 423,383 | ||||
| 2017-07-27 | 2017-07-25 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1.01 | 12,500 | 25,025 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Olson Eric R | SYRS | Common Stock | D | 21.8500 | -12,500 | -273 | 0 | ||||
| 2017-07-27 | 2017-07-25 | 4 | Olson Eric R | SYRS | Common Stock | D | 1.0100 | 12,500 | 13 | 12,500 | ||||
| 2017-06-12 | 3 | AKKARAJU SRINIVAS by Samsara BioCapital, L.P. | SYRS | Common Stock | I | 1,441,440 | ||||||||
| 2017-06-12 | 3 | AKKARAJU SRINIVAS by Samsara BioCapital, L.P. | SYRS | Common Stock | I | 1,441,440 | ||||||||
| 2017-06-12 | 2017-06-08 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 14.26 | 11,000 | 11,000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 14.26 | 11,000 | 11,000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | SATO VICKI L | SYRS | Stock Option (right to buy) | D | 14.26 | 11,000 | 11,000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | NELSEN ROBERT | SYRS | Stock Option (right to buy) | D | 14.26 | 11,000 | 11,000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Patel Sanj K | SYRS | Stock Option (right to buy) | D | 14.26 | 11,000 | 11,000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 14.26 | 11,000 | 11,000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 14.26 | 11,000 | 11,000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 14.26 | 22,000 | 22,000 | |||||
| 2017-02-13 | 2017-02-09 | 5 | Young Richard A | SYRS | Common Stock | D | -106,667 | 426,665 | ||||||
| 2017-02-13 | 2017-02-10 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 10.90 | 63,500 | 63,500 | |||||
| 2017-02-13 | 2017-02-10 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 10.90 | 40,000 | 40,000 | |||||
| 2017-02-13 | 2017-02-10 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 10.90 | 63,500 | 63,500 | |||||
| 2017-02-13 | 2017-02-10 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 10.90 | 175,000 | 175,000 | |||||
| 2017-02-13 | 2017-02-10 | 4 | Kuvalanka Kyle D. | SYRS | Stock Option (right to buy) | D | 10.90 | 78,000 | 78,000 | |||||
| 2017-01-30 | 2017-01-27 | 4 | WIRTH PETER | SYRS | Stock Option (Right to Buy) | D | 10.76 | 22,000 | 22,000 | |||||
| 2016-09-29 | 2016-09-27 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 13.30 | 105,000 | 105,000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | NELSEN ROBERT | SYRS | Stock Option (right to buy) | D | 12.59 | 22,000 | 22,000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 12.59 | 22,000 | 22,000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 12.59 | 22,000 | 22,000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Bancel Stephane | SYRS | Stock Option (right to buy) | D | 12.59 | 22,000 | 22,000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 12.59 | 22,000 | 22,000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Patel Sanj K | SYRS | Stock Option (right to buy) | D | 12.59 | 22,000 | 22,000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | SATO VICKI L | SYRS | Stock Option (right to buy) | D | 12.59 | 22,000 | 22,000 | |||||
| 2016-09-19 | 2016-09-16 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 12.17 | 75,000 | 75,000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 12.59 | 22,000 | 22,000 | |||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Series B Preferred Stock | D | -1,589,269 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Series A-3 Preferred Stock | D | -7,500,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Series A-2 Preferred Stock | D | -5,000,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Series A-1 Preferred Stock | D | -1,000,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 12.5000 | 400,000 | 5,000 | 4,637,137 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 423,805 | 4,237,137 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 2,000,000 | 3,813,332 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 1,333,333 | 1,813,332 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 266,666 | 479,999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Series B Preferred Stock | I | -83,129 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Series B Preferred Stock | I | -4,366,825 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Common Stock | I | 12.5000 | 26,153 | 327 | 48,320 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Common Stock | I | 12.5000 | 373,847 | 4,673 | 1,538,333 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Common Stock | I | 22,167 | 22,167 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Common Stock | I | 1,164,486 | 1,164,486 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series B Preferred Stock | I | -444,995 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series B Preferred Stock | I | -1,779,981 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-3 Preferred Stock | I | -1,500,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-3 Preferred Stock | I | -6,000,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-2 Preferred Stock | I | -1,000,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-2 Preferred Stock | I | -4,000,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-1 Preferred Stock | I | -200,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-1 Preferred Stock | I | -800,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 12.5000 | 80,000 | 1,000 | 918,664 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 12.5000 | 320,000 | 4,000 | 3,674,660 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 118,665 | 838,664 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 474,661 | 3,354,660 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 400,000 | 719,999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 1,600,000 | 2,879,999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 266,666 | 319,999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 1,066,666 | 1,279,999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 53,333 | 53,333 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 213,333 | 213,333 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -151,576 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -117,931 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -982,762 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -178,074 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -317,853 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 12.5000 | 9,373 | 117 | 49,793 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 12.5000 | 174,320 | 2,179 | 205,767 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 12.5000 | 104,670 | 1,308 | 366,739 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 12.5000 | 144,383 | 1,805 | 191,869 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 40,420 | 40,420 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 31,447 | 31,447 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 262,069 | 262,069 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 47,486 | 47,486 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 84,760 | 84,760 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Series B Preferred Stock | D | -1,994,471 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Series A-3 Preferred Stock | D | -500,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Series A-1 Preferred Stock | D | -500,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Series A-2 Preferred Stock | D | -500,000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Common Stock | D | 531,858 | 931,857 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Common Stock | D | 133,333 | 399,999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Common Stock | D | 133,333 | 399,999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Common Stock | D | 133,333 | 399,999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Series B Preferred Stock | I | -83,129 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Series B Preferred Stock | I | -4,366,825 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Common Stock | I | 12.5000 | 26,153 | 327 | 48,320 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Common Stock | I | 12.5000 | 373,847 | 4,673 | 1,538,333 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Common Stock | I | 22,167 | 22,167 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Common Stock | I | 1,164,486 | 1,164,486 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | AISLING CAPITAL III LP | SYRS | Series B Preferred Stock | D | -1,907,122 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | AISLING CAPITAL III LP | SYRS | Common Stock | D | 12.5000 | 400,000 | 5,000 | 908,565 | ||||
| 2016-07-06 | 2016-07-06 | 4 | AISLING CAPITAL III LP | SYRS | Common Stock | D | 508,565 | 508,565 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Series B Preferred Stock | I | -1,589,269 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Series A-3 Preferred Stock | I | -7,500,000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Series A-2 Preferred Stock | I | -5,000,000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Series A-1 Preferred Stock | I | -1,000,000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 12.5000 | 400,000 | 5,000 | 4,637,137 | ||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 423,805 | 4,237,137 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 2,000,000 | 3,813,332 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 1,333,333 | 1,813,332 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 266,666 | 479,999 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Simonian Nancy A | SYRS | Series A-2 Preferred Stock | D | -250,000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 66,666 | 370,702 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Series A-2 Preferred Stock | I | -150,000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Series A-2 Preferred Stock | I | -150,000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Series A-2 Preferred Stock | I | -150,000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Series A-2 Preferred Stock | D | -550,000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Common Stock | I | 40,000 | 40,000 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Common Stock | I | 40,000 | 40,000 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Common Stock | I | 40,000 | 40,000 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Common Stock | D | 146,666 | 146,666 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Bancel Stephane | SYRS | Series A-2 Preferred Stock | D | -100,000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Bancel Stephane | SYRS | Common Stock | D | 26,666 | 47,980 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | SYRS | Series B Convertible Preferred Stock | I | -508,566 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | SYRS | Series B Convertible Preferred Stock | I | -1,186,654 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | SYRS | Common Stock | I | 12.5000 | 120,000 | 1,500 | 628,566 | ||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | SYRS | Common Stock | I | 12.5000 | 280,000 | 3,500 | 1,466,654 | ||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | SYRS | Common Stock | I | 508,566 | 508,566 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | SYRS | Common Stock | I | 1,186,654 | 1,186,654 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | WuXi Healthcare Ventures II, L.P. | SYRS | Series B Preferred Stock | D | -1,589,269 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | WuXi Healthcare Ventures II, L.P. | SYRS | Common Stock | D | 423,805 | 423,805 | ||||||
| 2016-06-29 | 3 | Gray Nathanael | SYRS | Common Stock | D | 853,332 | ||||||||
| 2016-06-29 | 3 | Gray Nathanael | SYRS | Common Stock | D | 853,332 | ||||||||
| 2016-06-29 | 3 | JEB Syros Trust | SYRS | Common Stock | D | 703,332 | ||||||||
| 2016-06-29 | 3 | JEB Syros Trust | SYRS | Common Stock | D | 703,332 | ||||||||
| 2016-06-29 | 3 | Bancel Stephane | SYRS | Common Stock | D | 42,628 | ||||||||
| 2016-06-29 | 3 | Bancel Stephane | SYRS | Common Stock | D | 42,628 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A | SYRS | Common Stock | D | 768,072 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o William H. Cole | SYRS | Common Stock | I | 544,036 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o Bennett H. Cole | SYRS | Common Stock | I | 544,036 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o William H. Cole | SYRS | Common Stock | I | 544,036 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o Bennett H. Cole | SYRS | Common Stock | I | 544,036 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A | SYRS | Common Stock | D | 768,072 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426,664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426,664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426,664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426,664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426,664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426,664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426,664 | ||||||||
| 2016-06-29 | 3 | NELSEN ROBERT Shares held by ARCH Venture Fund VII, L.P. | SYRS | Common Stock | I | 426,666 | ||||||||
| 2016-06-29 | 3 | NELSEN ROBERT Shares held by ARCH Venture Fund VII, L.P. | SYRS | Common Stock | I | 426,666 | ||||||||
| 2016-06-29 | 3 | Perspecta Trust LLC Owned by the JEB Syros Trust, of which Perspecta Trust LLC is trustee. | SYRS | Common Stock | I | 703,332 | ||||||||
| 2016-06-29 | 3 | Perspecta Trust LLC Owned by the JEB Syros Trust, of which Perspecta Trust LLC is trustee. | SYRS | Common Stock | I | 703,332 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426,666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426,666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426,666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426,666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426,666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426,666 | ||||||||
| 2016-06-29 | 3 | Young Richard A | SYRS | Common Stock | D | 1,066,664 | ||||||||
| 2016-06-29 | 3 | Young Richard A | SYRS | Common Stock | D | 1,066,664 |
P
गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति की खुला बाज़ार या निजी खरीद
S
गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति का खुला बाज़ार या निजी बिक्री
A
कंपनी से प्रतिभूतियों का अनुदान, पुरस्कार या अन्य अधिग्रहण (जैसे एक ऑप्शन)
C
डेरिवेटिव का रूपांतरण
D
कंपनी को प्रतिभूतियों की बिक्री या हस्तांतरण
F
कंपनी से प्राप्त प्रतिभूतियों के हिस्से का उपयोग करके एक्सरसाइज मूल्य या कर दायित्व का भुगतान
G
इनसाइडर द्वारा या उसे प्रतिभूतियों का उपहार
K
इक्विटी स्वैप और समान हेजिंग लेनदेन
M
कंपनी से प्राप्त डेरिवेटिव प्रतिभूति के एक्सरसाइज या रूपांतरण (जैसे कि एक ऑप्शन)
V
किसी लेन-देन को स्वेच्छा से फॉर्म 4 पर रिपोर्ट किया गया
J
अन्य (लेन-देन का वर्णन करने वाले फ़ुटनोट के साथ)
